Gufic Biosciences Limited

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange about a copy of newspaper publication regarding the 42nd Annual General Meeting of the Company, scheduled to be held on September 04, 2026, through Video Conferencing / Other Audio Visual Means (VC/OAVM). The Company has also mentioned a commercial dispute under section 6 of the Commercial Courts Act, 2013, related to a lawsuit filed by Bank of India against the Company.

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange regarding the re-appointment of Mr. Pankaj J Gandhi as Whole Time Director of the company, effective September 07, 2026.

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange regarding the outcome of its Board Meeting held on July 31, 2026, where the Board has re-appointed Mr. Pankaj Jayakumar Gandhi as the Whole Time Director of the Company for a further term of 5 years.

Gufic Biosciences Limited

Gufic Biosciences Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended June 30, 2026.

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange about a copy of a newspaper publication regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Authority.

Gufic Biosciences Limited

Gufic Biosciences Limited has submitted a disclosure under SEBI Takeover Regulations, as per Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, filed by Jayesh P. Choksi.

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in securities of the Company shall remain closed for all the Designated Persons and their immediate relatives from Wednesday, July 01, 2026 till 48 hours after the declaration of Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.

Gufic Biosciences Limited

Gufic Biosciences Limited has informed the Exchange about a Special Window for Re-lodgement of Transfer and Dematerialization of Physical Shares, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026.